| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.036 | 0.4 |